These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 32192494)

  • 21. A comprehensive review of the role of lncRNAs in gastric cancer (GC) pathogenesis, immune regulation, and their clinical applications.
    Siri G; Yazdani O; Esbati R; Akhavanfar R; Asadi F; Adili A; Ebrahimzadeh F; Hosseini SME
    Pathol Res Pract; 2023 Jan; 241():154221. PubMed ID: 36563559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review.
    Zhao D; Wu T; Tan Z; Xu J; Lu Z
    Expert Rev Anticancer Ther; 2024 May; 24(5):239-251. PubMed ID: 38594965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNAs: emerging biomarkers in gastric cancer.
    Gu Y; Chen T; Li G; Yu X; Lu Y; Wang H; Teng L
    Future Oncol; 2015; 11(17):2427-41. PubMed ID: 26289363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer.
    Sun W; Jiang C; Ji Y; Xiao C; Song H
    Biomed Res Int; 2021; 2021():8853269. PubMed ID: 33506041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
    Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications.
    Tan H; Zhang S; Zhang J; Zhu L; Chen Y; Yang H; Chen Y; An Y; Liu B
    Theranostics; 2020; 10(19):8880-8902. PubMed ID: 32754285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomal non‑coding RNAs: Novel biomarkers with emerging clinical applications in gastric cancer (Review).
    Lu X; Zhang Y; Xie G; Ding Y; Cong H; Xuan S
    Mol Med Rep; 2020 Nov; 22(5):4091-4100. PubMed ID: 33000279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of long non-coding RNAs in gastric cancer metastasis.
    Yang ZG; Gao L; Guo XB; Shi YL
    World J Gastroenterol; 2015 May; 21(17):5220-30. PubMed ID: 25954095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
    Shang C; Guo Y; Zhang J; Huang B
    Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
    Lan H; Yuan J; Zeng D; Liu C; Guo X; Yong J; Zeng X; Xiao S
    Front Genet; 2021; 12():693259. PubMed ID: 34512721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance.
    Zhang X; Xie K; Zhou H; Wu Y; Li C; Liu Y; Liu Z; Xu Q; Liu S; Xiao D; Tao Y
    Mol Cancer; 2020 Mar; 19(1):47. PubMed ID: 32122355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircRNA: A new class of targets for gastric cancer drug resistance therapy.
    Zheng Y; Li Z; Wang Y; Chen W; Lin Y; Guo J; Ye G
    Pathol Oncol Res; 2023; 29():1611033. PubMed ID: 37065861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis.
    Wan X; Ding X; Chen S; Song H; Jiang H; Fang Y; Li P; Guo J
    Tumour Biol; 2015 Feb; 36(2):521-32. PubMed ID: 25636450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated Profiling Revealed Potential Regulatory Networks Among Long Noncoding RNAs and mRNAs in Mucosal Gastric Cancer.
    Sun KK; Shen XJ; Yang D; Jiao Y; Wu XY
    Technol Cancer Res Treat; 2020; 19():1533033820930119. PubMed ID: 32468960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer.
    Zhou H; Feng B; Abudoureyimu M; Lai Y; Lin X; Tian C; Huang G; Chu X; Wang R
    Life Sci; 2020 Nov; 261():118362. PubMed ID: 32871184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
    Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silence of Long Noncoding RNA NEAT1 Inhibits Malignant Biological Behaviors and Chemotherapy Resistance in Gastric Cancer.
    Zhang J; Zhao B; Chen X; Wang Z; Xu H; Huang B
    Pathol Oncol Res; 2018 Jan; 24(1):109-113. PubMed ID: 28401449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.